4//SEC Filing
Stone Christopher Lewis 4
Accession 0000882104-18-000104
CIK 0000882104other
Filed
Sep 26, 8:00 PM ET
Accepted
Sep 27, 4:41 PM ET
Size
5.6 KB
Accession
0000882104-18-000104
Insider Transaction Report
Form 4
Stone Christopher Lewis
VP and General Counsel
Transactions
- Award
Stock Option (right to buy)
2018-09-25+339,623→ 339,623 totalExercise: $2.52Exp: 2028-09-25→ Common stock (339,623 underlying)
Footnotes (1)
- [F1]The stock options will vest on a monthly basis pro rata over the 48 months following January 1, 2018, provided that the recipient's continuous service has not terminated prior to the applicable vesting date, subject to earlier vesting upon a change in control and certain qualifying terminations of employment provided in the severance agreement between the issuer and the recipient.
Documents
Issuer
PDL BIOPHARMA, INC.
CIK 0000882104
Entity typeother
Related Parties
1- filerCIK 0001453373
Filing Metadata
- Form type
- 4
- Filed
- Sep 26, 8:00 PM ET
- Accepted
- Sep 27, 4:41 PM ET
- Size
- 5.6 KB